IL312470A - Novel proteins - Google Patents

Novel proteins

Info

Publication number
IL312470A
IL312470A IL312470A IL31247024A IL312470A IL 312470 A IL312470 A IL 312470A IL 312470 A IL312470 A IL 312470A IL 31247024 A IL31247024 A IL 31247024A IL 312470 A IL312470 A IL 312470A
Authority
IL
Israel
Prior art keywords
new proteins
proteins
new
Prior art date
Application number
IL312470A
Other languages
English (en)
Hebrew (he)
Inventor
Rebecca Ashfield
Philip Huxley
Original Assignee
Ducentis Biotherapeutics Ltd
Rebecca Ashfield
Philip Huxley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ducentis Biotherapeutics Ltd, Rebecca Ashfield, Philip Huxley filed Critical Ducentis Biotherapeutics Ltd
Publication of IL312470A publication Critical patent/IL312470A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL312470A 2021-11-03 2022-11-03 Novel proteins IL312470A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2115803.5A GB202115803D0 (en) 2021-11-03 2021-11-03 Novel proteins
PCT/GB2022/052764 WO2023079278A1 (en) 2021-11-03 2022-11-03 Novel proteins

Publications (1)

Publication Number Publication Date
IL312470A true IL312470A (en) 2024-06-01

Family

ID=78828504

Family Applications (1)

Application Number Title Priority Date Filing Date
IL312470A IL312470A (en) 2021-11-03 2022-11-03 Novel proteins

Country Status (10)

Country Link
US (1) US20250026805A1 (cg-RX-API-DMAC7.html)
EP (1) EP4426719A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024542096A (cg-RX-API-DMAC7.html)
KR (1) KR20240099427A (cg-RX-API-DMAC7.html)
CN (1) CN118369334A (cg-RX-API-DMAC7.html)
AU (1) AU2022381844A1 (cg-RX-API-DMAC7.html)
CA (1) CA3236737A1 (cg-RX-API-DMAC7.html)
GB (1) GB202115803D0 (cg-RX-API-DMAC7.html)
IL (1) IL312470A (cg-RX-API-DMAC7.html)
WO (1) WO2023079278A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2626300A (en) * 2022-12-08 2024-07-24 Ducentis Biotherapeutics Ltd Mutated CD200 proteins and methods of use therof
GB202306711D0 (en) * 2023-05-05 2023-06-21 Ducentis Biotherapeutics Ltd Novel proteins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637481A (en) 1993-02-01 1997-06-10 Bristol-Myers Squibb Company Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
DE69226871T3 (de) 1991-06-27 2009-09-24 Bristol-Myers Squibb Co. CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
EP1171154A2 (en) 1999-04-13 2002-01-16 Schering Corporation Uses of mammalian ox2 protein and related reagents
WO2008089022A2 (en) 2007-01-11 2008-07-24 Boehringer Ingelheim International Gmbh Cd200 and its receptor, cd200r, modulate bone mass via the differentiation of osteoclasts
GB201608197D0 (en) * 2016-05-10 2016-06-22 Ducentis Biotherapeutics Ltd Novel proteins

Also Published As

Publication number Publication date
KR20240099427A (ko) 2024-06-28
WO2023079278A1 (en) 2023-05-11
EP4426719A1 (en) 2024-09-11
CA3236737A1 (en) 2023-05-11
GB202115803D0 (en) 2021-12-15
JP2024542096A (ja) 2024-11-13
CN118369334A (zh) 2024-07-19
US20250026805A1 (en) 2025-01-23
AU2022381844A1 (en) 2024-06-06

Similar Documents

Publication Publication Date Title
EP4225364A4 (en) Prefusion-stabilized hmpv f proteins
EP4281085A4 (en) MODIFIED DOUBLE-STRANDED OLIGONUCLEOTIDES
EP4137404A4 (en) Multicopter
EP4400482A4 (en) GLASS BODY
EP4107782A4 (en) MICROARRAYS
DK3737402T5 (da) Modificeret protein
EP4491731A4 (en) MODIFIED PROTEIN-GLUTAMINASE
EP4063561C0 (en) REFINER SEGMENT
EP4190803A4 (en) SIRPa-FC FUSION PROTEIN
EP4495244A4 (en) MODIFIED GLUTAMINASE PROTEIN
IL314723A (en) Novel peptides
EP4163277C0 (en) NEW PYRAZOLE DERIVATIVES
EP4481051A4 (en) D-ALLULOSE-3-MODIFIED EPIMERASE
EP4137402A4 (en) MULTICOPTER
IL311448A (en) Polypeptide
EP4433585A4 (en) NEW OMNI CRISPR NUCLEASE
IL311773A (en) Peptide
EP4335867A4 (en) Novel protein
EP4289123C0 (de) Containervermittelte anwendungskonfiguration
EP4172389A4 (en) PROTEIN SCAFFOLD
EP4154884A4 (en) Anti-sars-cov-2 durg
EP4406961A4 (en) PEPTIDE
EP4548671A4 (en) CONFIGURATION OF MULTIPLE MEASUREMENT INTERVALS
EP4288727C0 (de) Cryosauna
EP4176212C0 (fr) Ilot climatique